CLINICAL_TRIALS
trial_result
· 2009-07-08
Clinical Trial Update: Lyrica (Pregabalin) Administered as an Add-on Therapy for Partial Seizures (LEADER). [Phase 4]
Summary
Phase 4 trial evaluating pregabalin as add-on therapy for partial seizures in epilepsy; completed with posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | Conditions: Epilepsy | Phase 4 | Status: COMPLETED | Results posted: 2009-07-08